Raze Therapeutics, Inc.

Organization

Cambridge, MA, US

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Caffeine inhibitors of MTHFD2 and uses thereof
- Patent number 12,187,728
- Issue date Jan 7, 2025
- Raze Therapeutics, Inc.
- Nello Mainolfi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
3-phosphoglycerate dehydrogenase inhibitors and uses thereof
- Patent number 11,634,412
- Issue date Apr 25, 2023
- RAZE THERAPEUTICS, INC.
- Nello Mainolfi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
3-phosphoglycerate dehydrogenase inhibitors and uses thereof
- Patent number 11,535,593
- Issue date Dec 27, 2022
- RAZE THERAPEUTICS, INC.
- Nello Mainolfi
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Caffeine inhibitors of MTHFD2 and uses thereof
- Patent number 11,370,792
- Issue date Jun 28, 2022
- RAZE THERAPEUTICS, INC.
- Nello Mainolfi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
SHMT inhibitors and uses thereof
- Patent number 11,091,451
- Issue date Aug 17, 2021
- RAZE THERAPEUTICS, INC.
- Nello Mainolfi
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
3-phosphoglycerate dehydrogenase inhibitors and uses thereof
- Patent number 11,014,882
- Issue date May 25, 2021
- RAZE THERAPEUTICS, INC.
- Nello Mainolfi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
3-phosphoglycerate dehydrogenase inhibitors and uses thereof
- Patent number 10,954,220
- Issue date Mar 23, 2021
- RAZE THERAPEUTICS, INC.
- Nello Mainolfi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
3-PHOSPHOGLYCERATE DEHYDROGENASE INHIBITORS AND USES THEREOF
- Publication number 20230348386
- Publication date Nov 2, 2023
- Raze Therapeutics, Inc.
- Nello Mainolfi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
3-PHOSPHOGLYCERATE DEHYDROGENASE INHIBITORS AND USES THEREOF
- Publication number 20230312536
- Publication date Oct 5, 2023
- Raze Therapeutics, Inc.
- Nello Mainolfi
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SHMT INHIBITORS AND USES THEREOF
- Publication number 20230061841
- Publication date Mar 2, 2023
- Raze Therapeutics, Inc.
- Nello Mainolfi
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CAFFEINE INHIBITORS OF MTHFD2 AND USES THEREOF
- Publication number 20230067237
- Publication date Mar 2, 2023
- Raze Therapeutics, Inc.
- Nello Mainolfi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
3-PHOSPHOGLYCERATE DEHYDROGENASE INHIBITORS AND USES THEREOF
- Publication number 20230009122
- Publication date Jan 12, 2023
- Raze Therapeutics, Inc.
- Nello Mainolfi
- C07 - ORGANIC CHEMISTRY
Information Patent Application
3-PHOSPHOGLYCERATE DEHYDROGENASE INHIBITORS AND USES THEREOF
- Publication number 20220017464
- Publication date Jan 20, 2022
- Raze Therapeutics, Inc.
- Nello Mainolfi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SHMT INHIBITORS AND USES THEREOF
- Publication number 20190345119
- Publication date Nov 14, 2019
- Raze Therapeutics, Inc.
- Nello Mainolfi
- C07 - ORGANIC CHEMISTRY
Information Patent Application
3-PHOSPHOGLYCERATE DEHYDROGENASE INHIBITORS AND USES THEREOF
- Publication number 20190071400
- Publication date Mar 7, 2019
- Raze Therapeutics, Inc.
- Nello Mainolfi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
3-PHOSPHOGLYCERATE DEHYDROGENASE INHIBITORS AND USES THEREOF
- Publication number 20190071431
- Publication date Mar 7, 2019
- Raze Therapeutics, Inc.
- Nello Mainolfi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CAFFEINE INHIBITORS OF MTHFD2 AND USES THEREOF
- Publication number 20180370972
- Publication date Dec 27, 2018
- Raze Therapeutics, Inc.
- Nello Mainolfi
- C07 - ORGANIC CHEMISTRY

Raze Therapeutics, Inc.

Organization

Patents Grantslast 30 patents

Caffeine inhibitors of MTHFD2 and uses thereof

3-phosphoglycerate dehydrogenase inhibitors and uses thereof

3-phosphoglycerate dehydrogenase inhibitors and uses thereof

Caffeine inhibitors of MTHFD2 and uses thereof

SHMT inhibitors and uses thereof

3-phosphoglycerate dehydrogenase inhibitors and uses thereof

3-phosphoglycerate dehydrogenase inhibitors and uses thereof

Patents Applicationslast 30 patents

3-PHOSPHOGLYCERATE DEHYDROGENASE INHIBITORS AND USES THEREOF

3-PHOSPHOGLYCERATE DEHYDROGENASE INHIBITORS AND USES THEREOF

SHMT INHIBITORS AND USES THEREOF

CAFFEINE INHIBITORS OF MTHFD2 AND USES THEREOF

3-PHOSPHOGLYCERATE DEHYDROGENASE INHIBITORS AND USES THEREOF

3-PHOSPHOGLYCERATE DEHYDROGENASE INHIBITORS AND USES THEREOF

SHMT INHIBITORS AND USES THEREOF

3-PHOSPHOGLYCERATE DEHYDROGENASE INHIBITORS AND USES THEREOF

3-PHOSPHOGLYCERATE DEHYDROGENASE INHIBITORS AND USES THEREOF

CAFFEINE INHIBITORS OF MTHFD2 AND USES THEREOF

Trademarklast 30 trademarks